The immediate responses to aerosolized staphylococcal enterotoxin B (SEB) in respiratory toxic shock were studied in the circulation of rhesus monkeys with low antibody levels following immunization with SEB toxoid-containing microspheres. Both the surviving and dying monkeys had toxic shock syndrome 4-48 h after SEB challenge and all showed three distinctive patterns of immediate responses. 
Introduction
Staphylococcal enterotoxin B (SEB) is frequently associated with non-menstrual toxic shock syndrome. It accounts for most of the cases that are not associated with toxic shock syndrome toxin-1 (1, 2) . In many of these cases, the enterotoxin-producing staphylococci enter the openings of (3) (4) (5) . Because antibiotic-resistant and toxin-producing staphylococci are found on mucosae, particularly in the nose and throat, respiratory toxic shock may become an increasingly serious problem during outbreaks and epidemics of respiratory infectious diseases.
The mechanism of respiratory SEB-induced toxic shock in humans remains unclear. Although mice are naturally resistant to SEB intoxication (6) , relatively extensive studies have been conducted in mice due to the convenience of using mice in experimental manipulations, and to the availability of inbred strains, of large numbers at low cost, and of mAb reagents to cytokines and cell surface markers. These mouse studies have suggested that the most likely cause of SEB-induced toxic shock is the massive activation of the immune system by SEB (7) (8) (9) . SEB is a superantigen (7) (8) (9) (10) (11) . It binds to and forms complexes with MHC class II antigens on antigenpresenting cells, and the SEB-MHC class II-antigen complexes are then presented to and activate T cells bearing certain TCR V β elements (7) (8) (9) (10) (11) . Since SEB-reactive T cells and antigen-presenting cells are large cell populations, activation of these cells may elicit the production of massive amounts of various cytokines which may then directly or indirectly cause the disease (7) (8) (9) (10) (11) . However, whether and how these cellular and cytokine events occur and whether and how the neuroimmune system (12) responds to moderate intoxication in respiratory toxic shock in humans remains to be elucidated.
Monkeys are the most sensitive animal species next to humans to SEB intoxication (13) . The illness caused by SEB in monkeys shares many pathologic features with the disease caused by SEB in humans; many of these features are generally not seen in other animals (13) . However, as with humans, the pathogenesis of SEB toxic shock, even its initial stages, in monkeys is still unclear. Recently, we conducted a study on the efficacy of an SEB vaccine candidate, SEB toxoid-containing microspheres, in protecting monkeys against respiratory toxic shock caused by a challenge with aerosolized SEB (14) . This vaccine-testing study provided an opportunity to investigate in monkeys the cellular, cytokine and neuroendocrine responses in the blood circulation immediately following SEB aerosol challenge. The present report summarizes this study using a select group of monkeys, all of which had low antibody levels and some of which had antibody levels close to those of non-immunized monkeys. We have found that the immediate responses are characterized by three distinctive patterns in all the monkeys, which may be due to the superantigenicity of SEB and to possible activation effects of SEB on NK cells and non-lymphoid cells. The differences in the levels of anti-SEB antibodies between the surviving and dying monkeys are probably responsible for the differences in some cellular, cytokine and neuroendocrine responses. Because the surviving and dying monkeys were equally sick with toxic shock syndrome 4-48 h later, the responses that are similar in these two groups may be the basic cause that initiates the toxic shock, while the responses that are significantly different may compound those similar responses leading to the ultimate outcome of the dying monkeys.
Methods

Materials and isotopes
SEB prepared according to the method of Schantz et al. (15) was obtained in lyophilized form from the US Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD. Concanavalin A (Con A) and phenol/ water-extracted lipopolysaccharide (LPS) from Salmonella typhimurium were obtained from Sigma (St Louis, MO). RPMI 1640 medium was purchased from Gibco/Life Technologies (Grand Island, NY). 5-125 I-iodo-2Ј-deoxyuridine ([ 125 I]IUdR, sp. act. 850 µCi/ml) was obtained from NEN (Boston, MA). Ficoll-Paque (Ficoll 400 and sodium diatrizoate) was purchased from Pharmacia (Piscataway, NJ). ABTS (2,2Ј-azinodi-[3-ethyl-benzthiazoline sulfonic acid]) and hydrogen peroxide were purchased from Kirkegaard and Perry (Gaithersburg, MD).
Reagents mAb to human CD4, CD8, HLA-DR (an MHC class II antigen) and CD16 ϩ CD56 (NK cells) markers were purchased in a Simultest IMK kit from Becton Dickinson Immunocytometry Systems (San Jose, CA). These mAb were conjugated with either FITC or phycoerythrin. Monoclonal anti-IL-2 receptor α chain (CD25) and anti-T11 (CD2) antibodies were purchased from Becton Dickinson and Coulter (Hialeah, FL) respectively. Monoclonal and polyclonal antibodies against human IL-2, IL-4, IL-6, tumor necrosis factor (TNF)-α and IFN-γ were obtained from Genzyme (Cambridge, MA). Recombinant human IL-2, IL-4, IL-6, TNF-α and IFN-γ were also purchased from Genzyme, and horseradish peroxidase-conjugated goat anti-rabbit IgG (H ϩ L chain specific) was purchased from Zymed (South San Francisco, CA). These monoclonal reagents were the ones found to be reactive when tested on cells from monkeys and human volunteers.
Animal care and use
Ten rhesus monkeys (Macaca mulatta), male and female, weighing 2-3 kg, were part of a group of monkeys that were used in testing SEB toxoid-containing microspheres as a vaccine candidate (14) . The experiments conducted in monkeys strictly adhered to the 1985 Amendments to the Animal Welfare Act ( 
Monkeys
Blood was taken from a group of 10 monkeys in the course of a vaccine study that has been previously described (14) . These monkeys were chosen for study because of their low levels of anti-SEB antibodies. Nine monkeys were immunized and one monkey served as a saline-injected control. Monkeys were immunized by two administrations 7 weeks apart via combinations of mucosal and non-mucosal (intramuscular) routes of microspheres containing a total of 100 µg of SEB toxoid. However, at 10-11 weeks after the booster immunizations, three of them had antibody levels near to those of the non-immunized control and six of them had low antibody levels. The monkeys were each challenged with~7 LD 50 of aerosolized SEB. Shortly (4-6 h) and 2 days after SEB aerosol challenge, both the surviving and dying monkeys had essentially the same degree of toxic shock as judged by the severity of vomiting, diarrhea, anorexia and lethargy. The surviving monkeys started to recover 2-4 days later, while the dying monkeys went into more severe stages of toxic shock and were euthanized. There were six survivors and four that were lethally intoxicated. Irrespective of the immunization regimens, as expected, the survival and death of the monkeys correlated closely with the level of IgG and IgA anti-SEB antibodies in the circulation (14) . One week before SEB aerosol challenge, although antibody levels were relatively low, the surviving group had significantly higher circulating anti-SEB antibody levels than did the dying group (IgG, 822 Ϯ 379 versus 56 Ϯ 31 units/ml; IgA, 585 Ϯ 261 versus 46 Ϯ 20 units/ml; IgM, 336 Ϯ 171 versus 66 Ϯ 31 units/ml, expressed as mean Ϯ SEM). The saline-injected control died also and was grouped with the immunized dying monkeys since they had antibody levels close to each other. The variability in the antibody levels and the outcomes of challenges in the monkeys allowed us to observe responses that would be analogous to a broad cross-section of toxic shock patients who have low levels of natural anti-SEB antibodies.
The monkeys were individually exposed to aerosolized SEB for 10 min in a head-only exposure chamber modified from a Henderson apparatus. Subsequently, the chamber was flushed for 5 min with air. The aerosol in the exposure chamber was sampled using an all-glass impinger over the entire 10 min exposure period. The dose delivered was calculated from the concentration of SEB per liter of aerosol, individual body wt, the breathing frequency and the tidal volume of each monkey determined by a plethysmograph immediately before aerosol exposure (14, 16) .
Blood samples
Blood samples were obtained from the monkeys 1 and 2 weeks before and 20 and 90 min after SEB aerosol challenge. These were the time points when blood samples were available due to restrictions in vaccine testing and blood withdrawal in the monkeys. The blood samples were withdrawn from the monkeys at 9-11 a.m. to minimize the circadian variation. The average values of two pre-challenge blood samples from each monkey were used as baseline values for that monkey. Blood samples from 1 and 2 weeks before SEB challenge were used to set the pre-challenge baselines because of a concern about the effects of stress on the monkeys. The prechallenge baselines, as compared to the same variables of four other normal monkeys, were found to be within the limits of variation of the normal monkeys. The monkeys were anesthetized under Telazol (tiletamine hydrochloride plus zolazepam hydrochloride; A. H. Robins, Richmond, VA) during SEB challenge and blood withdrawal.
Flow cytometry
Blood samples (0.1 ml) obtained from the monkeys were immediately stained with fluorescein-or phycoerythrinconjugated mAb to leukocyte, monocyte and lymphocyte cell surface markers according to the instructions provided with the Simultest Kit. Cells were stained simultaneously with two mAb reagents bearing contrasting fluorochromes. Erythrocytes were lysed after the staining procedure. Cells were analyzed in a FACScan flow cytometer (Becton Dickinson), using the Paint-a-Gate or Lysys II program (Becton Dickinson). Ten thousand cells were analyzed for each test (16) . Monocytes and lymphocytes were identified by light scatter and by fluorescent staining with the corresponding mAb reagents. When stained with the anti-CD8 mAb conjugated with phycoerythrin, the CD8 ϩ cells showed two populations: a distinct population with very bright fluorescence and a broad population with less-bright fluorescence. The former cell population was defined as CD8 hi cells and the latter was defined as CD8 lo cells (16) . A similar staining pattern was seen for HLA-DR ϩ cells, and these two populations of cells were defined accordingly as HLA-DR hi cells and HLA-DR lo cells (16) .
Lymphocyte cultures and mitotic indices
Lymphocytes from the peripheral blood were separated by Ficoll-Paque gradient centrifugation (17) . They were cultured in 96-well culture plates in RPMI 1640 medium supplemented with 10% fetal bovine serum, 10 µg/ml gentamicin and 5ϫ 10 -5 M 2-mercaptoethanol. SEB, Con A and LPS at their maximal mitogenic concentrations (SEB, 2 µg/ml; Con A, 1 µg/ml; LPS, 100 µg/ml) were added when the cultures were established. Four to six cultures were stimulated with or without a mitogen. The lymphocytes were cultured in a humidified incubator at 37°C under 5% CO 2 , 95% air. Cells were harvested onto glass fiber filters in a cell harvester at day 4 after initiation of culture. Between 18 and 24 h before harvest, [ 125 I]IUdR (0.02 µCi/ml) was added to label the DNA of the actively dividing cells. Cells harvested on the glass fiber filters were processed for counting in a γ-counter (Multi Prias I; Packard Instruments, Downers Grove, IL). The spontaneous mitotic index of post-challenge blood samples was calculated as a ratio by dividing the c.p.m. of the cultures without mitogens (medium only) from post-challenge blood samples with those from pre-challenge blood samples. The stimulation index of the cultures stimulated with mitogens was calculated as the ratio of the average c.p.m. of the mitogenstimulated post-challenge cultures divided by the average c.p.m. of the post-challenge cultures with medium only. The mitotic index for the mitogen-stimulated cultures of postchallenge blood samples was then calculated as the product of the stimulation index and the spontaneous mitotic index of the cultures without mitogens. Calculated in this way, the index is expressed relative to the pre-challenge spontaneous proliferation.
ELISA
Cytokines from plasma samples were quantified by a sandwich ELISA. mAb to cytokines were used to coat each well of a 96-well Immulon II plate (Dynatech, Chantilly, VA). Polyclonal anti-cytokine antibodies conjugated with horse-radish peroxidase were used to detect the anti-cytokine antibodies. Serial dilutions of recombinant cytokines were used to construct a standard curve. Color was developed by the reaction of hydrogen peroxide and ABTS. Absorbance was measured in an ELISA reader (Bio-Tek, Winooski, VT) at 630 nm with background subtraction at 405 nm.
RIA
ACTH levels in monkey plasma were determined by competitive RIA using an 125 I Human ACTH Kit (ICN, Irvine, CA). A human ACTH standard curve was established at the same time. Each sample and standard was assayed in duplicate. Concentrations were determined based on the standard curve. The cortisol content of monkey plasma was also measured by competitive RIA using an IMMUCHEM 125 I Cortisol Assay Kit (ICN). One set of human cortisol standard curves was established at the same time. Each sample and standard was measured in triplicate. Concentrations were determined from the standard curve of human cortisol.
Statistical analysis and data presentation
The differences between surviving and dying monkeys were tested by Student's t-test (18) . To minimize variations among the monkeys and to overcome the problem of small numbers, the pre-challenge blood of each monkey was used as the control for that monkey. Except for lymphocyte cultures, data in the graphs are expressed as percent relative to prechallenge levels.
Results
Responses of T lymphocytes and HLA-DR ϩ cells
SEB is a superantigen (7) (8) (9) (10) . It binds to and forms complexes with MHC class II molecules on antigen-presenting cells. The SEB-class II antigen complexes are then presented to T cells and stimulate both the T cells and antigen-presenting cells to produce massive amounts of cytokines which appear to be the cause of toxic shock (7) (8) (9) (10) (11) . To study the superantigenic effects of SEB in monkeys, we therefore started with the immediate responses of T cells and antigen-presenting cells. Whole blood from the monkeys was withdrawn before SEB challenge, and at 20 and 90 min after challenge. Subsequently, the blood samples were stained with appropriate mAb reagents for cell membrane markers and analyzed by flow cytometry. The responses of T cells and antigenpresenting cells (HLA-DR ϩ cells), expressed as percent relative to pre-challenge levels, are shown in Figs 1 and 2 . The T cells as a whole (represented by CD2 ϩ cells), as well as the CD4 ϩ and CD8 ϩ T cell subsets examined individually, showed a similar pattern, i.e. there was a moderate increase in the frequency of T cells at 20 min, which was followed by a decrease at 90 min to a level near or below the initial levels ( Fig. 1) . However, there were no significant differences between the patterns shown by the surviving and dying monkeys in any of the T cell populations (Fig. 1) , although the dying monkeys tended to have more CD8 lo cells than the surviving monkeys at 20 min. The CD4/CD8 T cell ratios in both groups of monkeys remained fairly constant and were not significantly different from one another, although the CD4/ CD8 hi ratios increased significantly at 20 min and the higher ratios persisted at least 90 min following SEB challenge (Table  1) . These results suggest that SEB superantigenicity had a similar effect in the surviving and dying monkeys, although they had significantly different levels of anti-SEB antibodies (see the Monkeys section in Methods). SEB challenge caused a quick release of activated T cells, both SEB reactive and non-reactive, from tissues into the circulation (see the section below on Responses to mitogens in culture). The subsequent decreases of T cell frequencies in the circulation were apparently due to the migration of these T cell populations to tissues. Since CD4 ϩ T cells are the main T cells that recognize and respond to the SEB-class II complexes, the ratio of CD4 ϩ T cells to CD8 hi T cells increased after SEB challenge.
To further investigate the superantigenic effects of SEB, cells bearing MHC class II antigens (antigen-presenting cells) on their cell membranes were analyzed. A striking response was seen in the HLA-DR hi cell population. These cells showed a sharp decrease in frequency within the first 20 min, decreasing further at 90 min after SEB challenge, in both the surviving and dying monkeys (Fig. 2 , HLA-DR hi ). In contrast, HLA-DR lo cells showed a response pattern similar to that of the CD8 lo T cells (Fig. 2 , HLA-DR lo ): a moderate increase in frequency at 20 min that subsided at 90 min to a level somewhat higher than the initial level. The dying monkeys tended to have a moderate increase in the frequency of HLA-DR lo cells at 20 min. These results further illustrate the effect of SEB superantigenicity and suggest that most of the SEB binds quickly to HLA-DR hi cells in the circulation, due to the high density of HLA-DR antigens (class II antigens) on their cell surfaces. They were probably activated to express homing receptors or adhesion molecules and to migrate quickly to lymphoid tissues to present SEB-class II complexes to T cells. Due to competition with HLA-DR hi cells, there was probably not enough SEB bound to the HLA-DR lo cells present in the circulation to activate them; the increases in their numbers at 20 min were due to their release from tissues that are directly or indirectly affected by SEB.
Responses of PMN, monocytes, IL-2R ϩ cells and NK cells SEB can also directly or indirectly affect PMN, NK cells, monocytes and IL-2R ϩ cells (16, (19) (20) (21) . These lymphoid and non-lymphoid cells in the circulation were therefore analyzed by flow cytometry to study their relationships with other cell populations and cytokines. The responses of these cell populations were different in surviving and dying monkeys, and therefore may be due to the effects of anti-SEB antibodies. As summarized in Fig. 3 , PMN frequencies showed a steady pattern of increase, which was the opposite of the pattern seen with the NK cells. The monocytes and the IL-2R ϩ cells showed a similar response pattern, which was also similar to that of T cells (Fig. 1) : a brief increase in frequency at 20 min that declined to a level higher or lower than the initial levels (Mono and IL-2R respectively in Fig 3) . Interestingly, for PMN and monocytes, the dying monkeys tended to have higher frequencies than did the surviving monkeys; however, for NK cells and IL-2R ϩ cells, the dying monkeys had lower numbers. Compared to HLA-DR ϩ cells, NK cell frequencies in the dying monkeys showed a steady pattern of decrease similar to that of the HLA-DR hi cells (Fig. 2) . These results suggest that activation of NK cells, monocytes and T cells occurs quickly, and that antibodies to SEB have neutralizing effects in the circulation and in systemic tissues such that the responses of these cells and PMN were moderated in the surviving monkeys.
Responses to mitogens in culture
To study if the circulating lymphocytes were activated following SEB challenge, peripheral blood lymphocytes were cultured with or without mitogens (SEB, LPS and Con A) and mitotic indices were assessed by DNA synthesis based on [ 125 I]IUdR incorporation. The results are summarized in Fig.  4 . When cultured without mitogens, circulating lymphocytes from both the surviving and dying monkeys showed spontaneous mitosis (Medium in Fig. 4) , with the dying monkeys showing a significantly higher proliferation at 20 min following SEB challenge. This pattern of mitotic response was somewhat similar to that of the LPS-stimulated cultures, in which an enhanced response was seen at 20 min for lymphocytes from dying monkeys (LPS in Fig. 4 ). An even more prominent enhancement was seen in the SEB-stimulated cultures from the dying monkeys (SEB in Fig. 4 ). Interestingly, in Con Astimulated cultures, the lymphocytes of the dying monkeys tended to increase the level of enhancement (20-90 min), compared to those of the surviving monkeys (Con A in Fig. 4) . These results suggest that because of the lack of antibodies, cells (T cells, B cells and possibly macrophages) in the dying monkeys are more strongly activated such that both the T and B cells can undergo spontaneous mitosis or enhanced mitosis once they are stimulated with T or B cell mitogens.
Responses of cytokines
Cytokines have been suggested to be the major cause of toxicosis and toxic shock in SEB intoxication (7-9). They may affect cells both in the circulation and in tissues. To study cytokine responses, TNF-α, IFN-γ, IL-2, IL-4 and IL-6 in the blood circulation were quantified by ELISA. The results are summarized in Fig. 5 . Interestingly, IL-4 levels were very low (0.4-0.7 pg/ml) and were not significantly changed in any of the plasma samples of either the surviving or dying monkeys (data not shown). TNF-α levels showed essentially no significant changes in either group of monkeys, although the surviving monkeys tended to have a slight increase and the dying monkeys tended to have a slight decrease at 20 min. For IFN-γ, both the surviving and the dying monkeys had a burst at 20 min, which was more pronounced in the dying monkeys. This pattern of IFN-γ response was not coordinated with the pattern of IL-2 responses, suggesting that the two cytokines are produced and released by different organs or cell populations. While IL-2 levels at 90 min in the dying monkeys rose moderately, those in the surviving monkeys fell slightly; however, the differences in levels between the two groups of monkeys at 20 min were not statistically significant. Strikingly, IL-6 levels in both surviving and dying monkeys were elevated 4-to 6-fold at 20 min and the levels in the latter groups continued rising until they reached 12 times the pre-challenge level. Comparing the responses to those of cultures and cells (Figs 1-4) , the IFN-γ response pattern was similar to those of T cells, monocytes, IL-2R ϩ cells and lymphocyte mitogenesis stimulated with or without LPS or SEB. The IL-6 response was similar to those of PMN and of Con A mitogenesis but was in the opposite direction compared to the responses of HLA-DR hi cells and NK cells. All these results suggest that there is a systemic inflammation initiated immediately following SEB challenge, with concomitant cell activation caused by SEB superantigenicity. Activation of NK cells and their products such as IFN-γ and lytic enzymes augments the inflammation and T cell activation.
Responses of ACTH and cortisol
Cortisol is a natural defense substance released by the body in response to stress and infections (22) . ACTH controls the release of cortisol (22) . Both ACTH and cortisol releases are closely related to cytokine releases and actions in vivo (12, (22) (23) (24) . To study if these responses are elicited in SEB intoxication in monkeys, ACTH and cortisol levels in the plasma were quantified by RIA and their relationships with cytokines and cellular responses were analyzed. The results of ACTH and cortisol assays are summarized in Fig. 6 . Surprisingly, cortisol in both the surviving and dying monkeys showed a sharp decrease in the first 20 min after SEB challenge, although the cortisol levels in the surviving monkeys tended to level off at 90 min. The ACTH levels in the dying monkeys showed essentially the same pattern of decrease; however, the levels in the surviving monkeys appeared to recover by 90 min after the SEB challenge. Unexpectedly, the levels of both hormones, especially in the dying monkeys, were depressed rather than being elevated. Comparing the responses of cytokines and of cells (Figs 1-5 ), ACTH and cortisol responses are similar to HLA-DR hi and NK cells, but in the opposite direction compared to those of PMN-, IL-6-and Con A-stimulated cultures. These results suggest that immediately following SEB challenge the hypothalamic-pituitary-adrenal axis may be depressed by factors other than cytokines, resulting in a temporary breakdown of natural defenses.
Discussion
We have found in the present study three basic patterns of immediate responses in rhesus monkeys following SEB aero- sol challenge. The first pattern is one in which there is a moderate increase (burst) within the first 20 min followed by a decline at 90 min to a level either slightly higher or slightly lower than the pre-challenge level. The responses that show this pattern include: T cells taken as a whole (Fig. 1) , HLA-DR lo cells (Fig. 2) , monocytes and IL-2R ϩ cells (Fig. 3) , spontaneous mitosis and LPS and SEB mitogenesis in dying monkeys (Fig. 4) , and IFN-γ release (Fig. 5) . The second pattern of response was a sharp decrease within the first 20 min followed by a further decrease over the period from 20 to 90 min after challenge. The responses that followed this pattern are those of the HLA-DR hi cells (Fig. 2) , NK cells in the dying monkeys (Fig. 3 ), ACTH and cortisol (Fig. 6) . The third pattern was in the opposite direction of the second response pattern: there was an increase in the first 20 min followed by a continuation at the same level or an increase to higher levels. Responses that fell into this category are the responses of PMN (Fig. 3) , Con A mitogenesis (Fig. 4 ) and IL-6 (Fig. 5) . These three patterns of responses, although complicated, are distinct from each other and are consistent from one monkey to another. They act in concert in the initiation of toxic shock and may be useful indicators for studying and managing SEB-induced toxic shock in humans. By examining together the three patterns of immediate responses and CD4/CD8 T cell ratios (Table 1) , there appears to be mainly two types of sequential reactions, which are magnified at 90 min, and may be magnified further and proceed in concert to cause toxic shock later. These sequential reactions are inter-related but are caused separately by the superantigenicity of SEB and by the activation effects of SEB on NK cells and non-lymphoid cells, all of which occur both in the circulation and in tissues. Consistent with the direct effects of SEB superantigenicity are the increase in CD4/CD8 hi ratios shown in Table 1 and the responses included in the first pattern plus those of HLA-DR hi cells, Con A mitogenesis and IL-2. The sharp decrease in the numbers of HLA-DR hi cells suggests rapid binding and activation of these cells by SEB. The activated HLA-DR hi cells seem to quickly acquire homing receptors or adhesion molecules (selectins and integrins) and migrate to lymphoid tissues (25, 26) . The first place they enter the lymphoid tissue is the T cell area where they quickly interact with and present SEB-class II complexes to SEB-reactive T cells and activate them, resulting in the production of large amounts of cytokines which further activate both SEB-reactive and non-reactive cells. This interaction, activation and cytokine production process can also happen to the HLA-DR antigen-bearing cells (B cells and macrophages) and T cells already present in the lymphoid tissue when SEB directly enters the lymphoid tissues. The increases in CD4/CD8 hi T cell ratios (Table 1) is not yet known in monkeys which TCR V β elements are reactive with SEB. However, in the present study, both SEB-reactive and non-reactive T cells were apparently activated in the monkeys and were released into the circulation, as shown by the burst of T cells at 20 min, and by SEB and Con A mitogenesis in culture (Figs 1 and 4) . The activation effects of SEB on NK cells and non-lymphoid cells can be seen prominently in the dying monkeys. SEB binds to and activates non-lymphoid cells such as macrophages and endothelial cells that bear class II antigens to produce nitric oxide (30) , a mediator that modulates vascular reactions in acute inflammation (31, 32) . NK cells are known to bear class II antigens on the cell surface and are stimulated by SEB to produce IFN-γ (19, 20) . The quick disappearance of NK cells in the dying monkeys is consistent with the binding of SEB to NK cells which are probably activated and migrate similarly as the HLA-DR hi cells (Figs 2 and 3) (25, 26, 33) . The activated NK cells both in the circulation and in tissues quickly produce IFN-γ as shown by the burst of IFN-γ at 20 min following SEB challenge (Fig. 5) ; they may also respond to chemokines and cytokines, and be involved in inflammation (34) . The IFN-γ produced by NK cells may augment the inflammatory reaction triggered by nitric oxide and expand the activation of lymphoid cells and non-lymphoid cells (macrophages and endothelial cells) which have been or have not been activated by the superantigenicity of SEB, leading to later toxic shock syndrome. The moderate increase of PMN and the exponential increase of IL-6 (Figs 3 and 5) appear to reflect the inflammatory reaction triggered by nitric oxide and augmented by NK cells and IFN-γ. The appearances of PMN and IL-6 are well known events in inflammatory reactions (35) (36) (37) . Furthermore, we have recently found that passive immunization against IFN-γ can protect mice against SEB-induced toxic shock (Komisar, unpublished observations). Both IFN-γ and IL-6 have been shown to be important initiation factors in SEB intoxication in mice (38) . In the present study, all the monkeys except one control were immunized with SEB toxoid-containing microspheres. Therefore, a question arose as to whether the immediate responses we saw in our monkeys truly represent those that occur in non-immunized monkeys challenged with SEB. SEB is a protein superantigen; SEB toxoid in the microspheres may have caused T cell depletion and anergy in monkeys after vaccination if it had retained superantigenicity (39) (40) (41) . Immunization with SEB toxoid-containing microspheres in monkeys may also elicit antibodies that cause type I IgEmediated anaphylactic hypersensitivity and type III immune complex-mediated hypersensitivity when monkeys are challenged with SEB. However, these possible reactions did not occur in our monkeys in the present study. This is apparently due to: (i) the loss of superantigenicity of the SEB toxoid in the microspheres, which was assessed by proliferation in mouse spleen cell cultures stimulated with the SEB toxoid and in peripheral lymphocyte cultures from our monkeys following immunization (Chen et al., unpublished results), (ii) no significant changes in the frequencies of T cells bearing SEB-reactive V β elements as enumerated in the blood circulation by flow cytometry in monkeys following immunization with the same microspheres in a separate experiment (Komisar and Small-Harris, unpublished results), and (iii) the fact that the surviving monkeys had low antibody levels and the dying monkeys had antibody levels close to those of the non-immunized control (see Methods). Furthermore, as with the monkeys in the previous studies (14, 16) , both the surviving and dying monkeys (including the unvaccinated control) all exhibited the symptoms of toxic shock syndrome, primarily vomiting, diarrhea, anorexia and lethargy. The earliest symptoms were vomiting and/or diarrhea at~4-6 h after challenge, and the anorexia and lethargy persisted until 24-48 h after SEB challenge. The monkeys with more severe illness went on to die at~48-60 h after challenge, rather than immediately following SEB challenge as would have been the case with an anaphylactic reaction. In addition, together with the study reported previously (14), we were unable to detect in any monkey a significant increase of histamine in either the plasma or bronchoalveolar lavage immediately after SEB challenge. There were no significant differences between the plasma histamine levels in the surviving monkeys and those in the dying monkeys either before or after SEB challenge. Post mortem pathologic examination of the dying monkeys did not reveal the characteristic features of IgE-mediated anaphylaxis or antigen-antibody complexes deposited in organs such as kidneys and liver (Hunt, unpublished observations). Interestingly, all the immediate responses in both the surviving and dying monkeys showed three distinctive patterns which were essentially similar between the two groups of monkeys. The vaccine candidate, the SEB toxoidcontaining microspheres, used in the present study, was developed in order to overcome the problem of anaphylactic shock that had occurred following several SEB challenges in monkeys that had been immunized with an earlier batch of SEB toxoid that was heavily polymerized with formalin. The SEB toxoid incorporated into the microspheres was prepared by a procedure different from the conventional toxoiding method of Warren et al. (42) ; it consisted mainly of monomers, dimers and trimers of detoxified SEB as evidenced by SDS gel electrophoresis (Komisar and Essiet, unpublished results). The antibodies elicited by the microspheres included an unusually high portion of IgA (14,16 and see Methods). Perhaps due to the high challenge dose of SEB, low levels of antibodies and the characteristics of the microspheres, of the new SEB toxoid, and of the IgA anti-SEB response, the immunized monkeys did not show signs of T cell anergy and depletion following vaccination and of anaphylaxis or immune complex-mediated inflammation following SEB challenge.
Although the syndrome of toxic shock and the patterns of immediate responses were similar in all the monkeys used in the present study, anti-SEB antibodies appeared to cause differences between the surviving and dying monkeys in some of the immediate responses. The dying monkeys generally showed more prominent responses than did the surviving monkeys. By statistical analyses comparing the surviving and dying monkeys, significant differences were seen in the responses of HLA-DR lo cells, IL-2R ϩ cells, monocytes, mitogenesis in cultures, NK cells, IL-2, IL-6 and ACTH. The responses of HLA-DR lo cells, IL-2R ϩ cells, monocytes and mitogenesis with or without LPS and SEB in cultures all showed significant differences between surviving and dying monkeys at 20 min, while the responses of NK cells, IL-2, IL-6, ACTH and Con A mitogenesis in cultures all showed significant differences only at 90 min, although the responses progressed continuously during the first 90 min period. However, anti-SEB antibodies did not seem to cause a significant difference between the surviving and dying monkeys in the inhibition of SEB binding to class II antigens. This was clearly seen in the responses of HLA-DR hi cells and further evidenced in a separate study in which rhesus monkeys were immunized in the same manner with the same SEB-toxoid microspheres and challenged with a higher dose (15 LD 50 ) of aerosolized SEB (14) . Antibodies in the pre-challenge plasma samples from the surviving and dying monkeys did not show significant differences in inhibiting the binding of SEB to the class II antigens on HuT-78 cells, a human leukemic T cell line (Komisar, unpublished observations). Since the surviving and dying monkeys were equally sick 4-48 h after SEB challenge, it is possible that SEB binding to class II antigen-bearing cells may initiate the basic reactions of toxic shock, which may be exacerbated by activated T cells, leading to death by added reactions of monocytes, NK cells and tissues, and further by the effects of large amounts of IL-2 and IL-6. The depressed ACTH and cortisol responses in the dying monkeys may have impaired their ability to control the harmful activation of the immune system (vide infra). However, further studies are needed to verify this possibility.
Glucocorticoids suppress immune and inflammatory responses (12, (22) (23) (24) . They are produced by the adrenal cortex and are regulated in part through the action of cytokines (12, (22) (23) (24) . During stress and inflammation, the levels of ACTH and glucocorticoids are generally elevated in the circulation (12, (22) (23) (24) . Surprisingly, however, reduced levels of ACTH and cortisol were seen in the present study immediately following SEB challenge. The mechanism by which the levels were lowered is not known. Nevertheless, the decrease in the levels of cortisol was consistent with the response of HLA-DR hi cells and NK cells. The ACTH and cortisol responses were similar to those of HLA-DR hi cells and NK cells (Figs 2  and 3 ), but were negatively correlated with the responses of PMN (Fig. 3) , IL-2 and IL-6 (Fig. 4) . Thus, it is possible that some of the HLA-DR hi cells, PMN, NK cells and class II antigen-bearing cells in tissues may directly or indirectly induce a factor or factors that quickly inhibit the action of IL-2 and IL-6, which are known to act on the hypothalamicpituitary-adrenal axis to release ACTH and cortisol (12, (22) (23) (24) . Recently, corticostatic peptides have been found to be produced and released by granulocytes in the circulation and by the lungs of humans as well as by the bone marrow of guinea pigs (43) (44) (45) . These cells and organs are the major tissue sites where aerosolized SEB goes immediately following challenge. Nonetheless, this decrease in the levels of glucocorticoid hormones may remove the controls on cytokines and cellular responses, leading to later SEB toxicosis and toxic shock.
From recent post mortem pathology studies (46; Oyejide et al. and Hunt, unpublished observations), monkeys that died of SEB aerosol intoxication showed tissue reactions suggesting systemic inflammation and the effects of SEB superantigenicity. The prominent features were the presence of lymphoblasts and large mononuclear cells in the blood vessels and in tissues, and edema in tissues, particularly the lungs. In the present study, the decrease in the numbers of all lymphoid cells at 90 min was similar to the early signs of lymphopenia seen in SEB toxic shock patients. The responses of PMN, IL-2 and IL-6 as well as of activated T cells reactive to Con A and the disappearance of many HLA-DR hi cells and NK cells from the circulation were prominent at 90 min following SEB challenge, which is consistent with the features seen in the post mortem pathologic examinations. However, the present study has provided information only about the initial stage of pathogenesis. Further studies on the time course of the responses that occur between the challenge and the time of death, particularly the later stages, are needed to better understand the mechanism of SEB-induced toxic shock.
